CVR 43616595Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København ØFounded 31 Oct 2022
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Biomia ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
4
CVR, Aug 2026
-4 (-50%) over 12 months
Gross profit
-2.6M
DKK, annual report 2025
Result
-5.9M
DKK, annual report 2025
Equity
5.5M
DKK, annual report 2025
BY Capital 3 GmbH & Co. KG20% to under 25% of capital and votes
ZANDY Holding ApSCVR 43567942, 15% to under 20% of capital and votes
and 5 moreOperating company
Dandex estimate: 4 employees registered in 2026Michael Krogh Jensensince 31 Oct 2022
Owners of 5% or more. CVR registers shares in bands, not exact figures.
CVR 3751911110% to under 15% of capital and votesclass A, Bnotified 11 Aug 2026since 31 Oct 2022
CVR 4356794215% to under 20% of capital and votesclass Anotified 20 Sep 2023since 31 Oct 2022
CVR 4359871615% to under 20% of capital and votesclass Anotified 2 Aug 2023since 31 Oct 2022
CVR 436077745% to under 10% of capital and votesclass Anotified 20 Sep 2023since 31 Oct 2022
CVR 441572175% to under 10% of capital and votesclass Anotified 2 Aug 2023since 7 Jul 2023
20% to under 25% of capital and votesclass Bnotified 20 Sep 2023since 2 Aug 2023
5% to under 10% of capital and votesclass Bsince 1 Sep 2023
CVR 378146605% to under 10% of capital and votesclass Anotified 20 Sep 202331 Oct 2022 to 20 Sep 2023
5% to under 10% of capital and votesclass B20 Sep 2023 to 11 Aug 2026
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Founded 31 Oct 2022.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Aug 2026, monthly: 4 employees, 3 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 8 | 8 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 4 | 4 | 4 | 4 | 4 |
| FTE | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 3 | 3 | 3 | 3 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Aug 2026, published 21 Oct 2026.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2025, DKK: Gross profit -2.6M, Operating profit -7.8M, Result for the year -5.9M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 8.3M, Equity 5.5M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2023 | 2024 | 2025 |
|---|---|---|---|
| Gross profit | -582 | -5,944 | -2,584 |
| Operating profit | -1,591 | -10,783 | -7,804 |
| Result for the year | -933 | -7,825 | -5,903 |
| Equity | 19,185 | 11,360 | 5,456 |
| Total assets | 19,636 | 15,547 | 8,312 |
| Employees (average) | 1 | 5 | 6 |
| Credit metrics (Dandex calculations) | |||
| EBITDA | Not reportednote 1 | -10,124 | -6,884 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||
| Employee growth (vækst i antal ansatte) | Not reportednote 2 | Not reportednote 3 | 20% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||
| Capex (investeringer i anlægsaktiver) | Not reportednote 4 | 4,099note 5 | 539note 5 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||
Not every period is a full year: 2023 covers 14 months (31 Oct 2022 to 31 Dec 2023). Changes against it compare periods of different length.
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Biomia ApS:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 1,308,448, cash price 1,055.20, implied value 66,488,152 | 1,055.20 | 1,308,448 | 66,488,152 | 63,010 | |
| IncreaseCashPaid in 1,000,330, cash price 1,055.20, implied value 65,179,704 | 1,055.20 | 1,000,330 | 65,179,704 | 61,770 | |
| IncreaseCashPaid in 530 | None | 530 | None | 60,822 | |
| IncreaseCashPaid in 7,065,997, cash price 1,015.38, implied value 61,219,014 | 1,015.38 | 7,065,997 | 61,219,014 | 60,292 | |
| IncreaseCashPaid in 13,559,928, cash price 1,017.02, implied value 54,240,728 | 1,017.02 | 13,559,928 | 54,240,728 | 53,333 | |
| FoundingCashPaid in 40,000 | None | 40,000 | None | 40,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
9 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Vedtægter ændret: 11.08.2026
Kapitalforhøjelsen er besluttet den 11.08.2026.
kr. 1.240,00, indbetalt kontant, kurs 105.520,00.
Kapitalen udgør herefter kr. 63.010,00.
Vedtægter ændret: 12.02.2026
Kapitalforhøjelsen er besluttet den 12.02.2026.
kr. 948,00, indbetalt kontant, kurs 105.520,00.
Kapitalen udgør herefter kr. 61.770,00.
Vedtægter ændret: 27.01.2026
Kapitalforhøjelsen er besluttet den 27.01.2026.
kr. 530,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 60.822,00.
Revision:
Tiltrådte:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 12.04.2024.
Ny adresse: Lersø Parkallé 44, 3., 2100 København Ø
Ny kommune: København
Vedtægter ændret: 20.09.2023
Kapitalforhøjelsen er besluttet den 20.09.2023.
kr. 6.959,00, indbetalt kontant, kurs 101.537,54.
Kapitalen udgør herefter kr. 60.292,00.
Vedtægter ændret: 02.08.2023
Kapitalforhøjelsen er besluttet den 02.08.2023.
kr. 13.333,00, indbetalt kontant, kurs 101.702,00.
Kapitalen udgør herefter kr. 53.333,00.
Kapitalen er opdelt i klasser.
Bestyrelse:
Fratrådte:
Jay D Keasling, den 02.08.2023, Jie Zhang, den 02.08.2023.
Tiltrådte:
Michael Krogh Jensen, den 02.08.2023.
Ny adresse: Kemitorvet 220, 2800 Kongens Lyngby
Ny kommune: Lyngby-Taarbæk
Stiftelsesdato: 31.10.2022.
Virkningsdato: 31.10.2022.
Seneste vedtægtsdato: 31.10.2022.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
CVR-NR. 37519111 Next Stage Ventures ApS, c/o Henrik Stage, Gl Strandvej 250, 3050 Humlebæk, den 31.10.2022, CVR-NR. 37814660 CSS Invest ApS, Lyngbakkevej 19, Søllerød, 2840 Holte, den 31.10.2022, CVR-NR. 43567942 ZANDY Holding ApS, c/o Jie Zhang, Højbovej 7A, 3460 Birkerød, den 31.10.2022, CVR-NR. 43598716 iobio Holding ApS, c/o Michael Krogh Jensen, Hellebækgade 17, 2., 2200 København N, den 31.10.2022, CVR-NR. 43607774 Keasling Biomanufacturing ApS, c/o Michael Krogh Jensen, Hellebækgade 17, 2., 2200 København N, den 31.10.2022.
Bestyrelse:
Henrik Stage, (formand), den 31.10.2022, Jay D Keasling, den 31.10.2022, Jie Zhang, den 31.10.2022.
Direktion:
Michael Krogh Jensen, (adm. dir), den 31.10.2022.
Selskabet tegnes af direktøren i forening med bestyrelsens formand, af direktøren i forening med et bestyrelsesmedlem, eller af den samlede bestyrelse.
Første regnskabsår:
31.10.2022 - 31.12.2023.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at drive forskning og udvikling indenfor, og kommercialisering af, produktion af plantebaserede naturstoffer ved hjælp af bioteknologi.
P-number 1028712150Lersø Parkallé 44, 2100 København Ø